摘要 |
Crystalline paroxetine methane sulfonate, crystalline paroxetine benzene sulfonate Crystalline paroxetine p-toluene sulfonate, and/or crystalline paroxetine p-chlorobenzene sulfonate. Processes for preparing these compounds and pharmaceutical compositions containing them. Also described is the use of these compounds in the treatment of depression (including depression arising from pre0menstrual tension), obsessive compulsive disorder, panic disorder, bulimia, anorexia, pain, obesity, senile dementia, migraine, and social phobia.
|